Clinical Trial Update: Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and immunogenicity of a live attenuated human metapneumovirus vaccine, with results describing safety outcomes and immune respon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Metapneumovirus Infection

Drugs mentioned

• Live attenuated human metapneumovirus vaccine (live attenuated human metapneumovirus vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Metapneumovirus | Phase 1 | Status: COMPLETED